MCK's Aroon Indicator triggered a bullish signal on November 11, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 355 similar instances where the Aroon Indicator showed a similar pattern. In 260 of the 355 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at 73%.
The Momentum Indicator moved above the 0 level on November 04, 2026. You may want to consider a long position or call options on MCK as a result. In 54 of 95 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 57%.
The Moving Average Convergence Divergence (MACD) for MCK just turned positive on November 04, 2026. Looking at past instances where MCK's MACD turned positive, the stock continued to rise in 34 of 52 cases over the following month. The odds of a continued upward trend are 65%.
Following a +7.24% 3-day Advance, the price is estimated to grow further. Considering data from situations where MCK advanced for three days, in 254 of 382 cases, the price rose further within the following month. The odds of a continued upward trend are 66%.
The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 5 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MCK declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 43%.
MCK broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Price Growth Rating for this company is 6 (best 1 - 100 worst), indicating outstanding price growth. MCK’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 6 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 73, placing this stock better than average.
The Tickeron Valuation Rating of 13 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-29.171) is normal, around the industry mean (14.423). MCK has a moderately high P/E Ratio (28.334) as compared to the industry average of (11.188). Projected Growth (PEG Ratio) (1.616) is also within normal values, averaging (2.016). Dividend Yield (0.004) settles around the average of (0.134) among similar stocks. P/S Ratio (0.265) is also within normal values, averaging (4.260).
The Tickeron PE Growth Rating for this company is 37 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
YOKE saw its Momentum Indicator move above the 0 level on October 13, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 22 similar instances where the indicator turned positive. In 17 of the 22 cases, the stock moved higher in the following days. The odds of a move higher are at 77%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 21 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The 10-day moving average for YOKE crossed bearishly below the 50-day moving average on October 12, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 2 of 4 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 50%.
The Aroon Indicator for YOKE entered a downward trend on November 02, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
MCK | ||
|---|---|---|
OUTLOOK RATING 1..100 | 39 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 13 Undervalued | |
PROFIT vs RISK RATING 1..100 | 6 | |
SMR RATING 1..100 | 100 | |
PRICE GROWTH RATING 1..100 | 6 | |
P/E GROWTH RATING 1..100 | 37 | |
SEASONALITY SCORE 1..100 | 49 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| MCK | YOKE | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 50% | N/A |
| Stochastic ODDS (%) | 1 day ago 41% | 2 days ago 55% |
| Momentum ODDS (%) | 1 day ago 57% | 2 days ago 77% |
| MACD ODDS (%) | 1 day ago 65% | N/A |
| TrendWeek ODDS (%) | 1 day ago 66% | 2 days ago 62% |
| TrendMonth ODDS (%) | 1 day ago 70% | 2 days ago 67% |
| Advances ODDS (%) | 7 days ago 66% | N/A |
| Declines ODDS (%) | 3 days ago 43% | N/A |
| BollingerBands ODDS (%) | 1 day ago 46% | N/A |
| Aroon ODDS (%) | 1 day ago 73% | 2 days ago 42% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
MCK’s FA Score shows that 3 FA rating(s) are green while .
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
MCK’s TA Score shows that 4 TA indicator(s) are bullish.
MCK (@Medical Distributors) experienced а +8.30% price change this weekfor the same time period.
The average weekly price growth across all stocks in the @Medical Distributors industry was -12.70%. For the same industry, the average monthly price growth was -15.74%, and the average quarterly price growth was -20.34%.
MCK is expected to report earnings on Feb 10, 2027.
Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.
A.I.dvisor indicates that over the last year, MCK has been closely correlated with COR. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if MCK jumps, then COR could also see price increases.
| Ticker / NAME | Correlation To MCK | 1D Price Change % | ||
|---|---|---|---|---|
| MCK | 100% | -0.26% | ||
| COR - MCK | 70% Closely correlated | +0.34% | ||
| CAH - MCK | 66% Closely correlated | +0.24% | ||
| HKPD - MCK | 10% Poorly correlated | +1.91% | ||
| FOCL - MCK | 9% Poorly correlated | +0.86% | ||
| AHG - MCK | 7% Poorly correlated | +10.40% | ||
More | ||||
A.I.dvisor tells us that YOKE and DOX have been poorly correlated (+16% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that YOKE and DOX's prices will move in lockstep.
| Ticker / NAME | Correlation To YOKE | 1D Price Change % | ||
|---|---|---|---|---|
| YOKE | 100% | N/A | ||
| DOX - YOKE | 16% Poorly correlated | -0.67% | ||
| CSX - YOKE | 15% Poorly correlated | +1.19% | ||
| MDLZ - YOKE | 14% Poorly correlated | +0.15% | ||
| MCK - YOKE | 13% Poorly correlated | +2.19% | ||
| TW - YOKE | 12% Poorly correlated | +1.08% | ||
More | ||||